surmount-1 trial tirzepatide obesity without diabetes weight loss In the (published in NEJM in July 2022), adults with #obesity treated with weekly tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor Tirzepatide cuts diabetes risk by

1 Agarwal A, Shaharyar A, Kumar A, Bhat MS, Mishra M

Conflict of Interest The authors declare no competing financial interest

Verify credentials

biochemical engineering can technically solve the half-life problem, and co-formulations can improve the absorption problem, but the higher doses required make for formidable raw ingredient costs.3 Turning Food into Drug Delivery Vehicles A solution to this problem may come from foregoing chemistry and turning, instead, to biology

It is produced by nerve cells in the liver and central nervous system and is involved in many body processes

Ms Horgan-Wallace hoped her experience would serve as a warning about the dangers of non-prescribed weight loss medication